ChIP-seq of ERa and PR in two ER+ breast cancer cell lines treated with and without estrogen and with and without progestins. Homo sapiens

Exploring effect of estrogen and progesterone/progestin treatment on ER and PR binding. Overall design: Two cell lines, four conditions (Vehicle, E2, Progesterone, E2+Progesterone), two factors (ERa, PR), all with three replicates.